基本分析
透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。
基本資料
個股的基本資料,以及所屬的類股和產業。
公司介紹
業務介紹
葛蘭素史克公司及其子公司在英國、美國和國際上從事製藥產品、疫苗、非處方藥品和與健康相關的消費品的創造、發現、開發、製造和營銷。該公司通過四個部門運營:製藥、製藥研發、疫苗和消費者保健。該公司提供的製藥產品包括治療領域的藥物,如呼吸系統、HIV、免疫炎症、腫瘤學、抗病毒、中樞神經系統、心血管和泌尿生殖系統、代謝、抗細菌和皮膚病。它還提供保健品,涵蓋保健、口腔健康、營養和皮膚健康等類別。該公司以噴霧劑、片劑、糖漿、喉片、口香糖和經皮貼片、膠囊、嬰兒糖漿滴劑、液體懸浮液、濕巾、凝膠、泡騰劑、牙膏、牙刷、漱口水、假牙黏合劑和清潔劑、外用乳膏和非藥用貼片、潤唇膏、軟糖和軟咀嚼片的形式提供其消費者保健產品。該公司與23andMe、Lyell Immunopharma, Inc.、諾華、賽諾菲SA、Surface Oncology、Progentec Diagnostics, Inc.、Alector, Inc.和CureVac AG.有合作協議,並與IDEAYA Biosciences, Inc.和Vir Biotechnology, Inc.有戰略合作夥伴關係。該公司曾稱為葛蘭素史克公司,於2022年5月更名為GSK公司。GSK公司成立於1715年,總部位於英國倫敦郊區的布倫特福德。
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。